Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
bayer
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
3
×
new york blog main
3
×
new york top stories
pfizer
3
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
alzheimer's disease
biogen
biotech
bristol-myers squibb
cancer immunotherapy
celgene
clinical trials
gilead sciences
johnson & johnson
merck
What
bio
drug
3
×
roundup
nash
news
acquisitions
aducanumab
albert
alzheimer’s
amyloid
angst
approved
bagged
biggest
billions
biogen
biogen’s
bourla
brammer
ceo
companies
company
crispr
digital
disease
effects
epidemic
failure
fatty
fda
felt
frenzied
future
growing
imports
known
led
liver
lost
maker
Language
unknown
Current search:
bayer
×
drug
×
" new york blog main "
×
" national top stories "
×
pfizer
×
@xconomy.com
5 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More